国泰中证生物医药ETF联接A(006756)资产负债表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
268,270.96 |
- |
61,947.32 |
138,024.18 |
| 存出保证金 |
50,557.26 |
34,031.41 |
14,593.12 |
10,777.86 |
| 交易性金融资产 |
540,501,858.06 |
572,499,876.95 |
609,724,046.92 |
601,496,090.22 |
| 其中：股票投资 |
- |
- |
- |
4,448,945.44 |
| 债券投资 |
- |
605,383.89 |
2,335,115.78 |
1,718,242.16 |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
- |
- |
- |
- |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
- |
- |
- |
| 应收申购款 |
4,080,533.91 |
1,127,734.05 |
1,172,561.11 |
1,280,544.12 |
| 其他资产 |
225,104.15 |
- |
94,895.41 |
- |
| 资产总计 |
580,639,725.07 |
610,825,118.89 |
646,762,803.78 |
640,334,235.02 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
5,249,256.20 |
- |
- |
- |
| 应付赎回款 |
4,896,249.73 |
2,809,806.01 |
2,139,476.66 |
2,937,248.19 |
| 应付管理人报酬 |
14,548.55 |
14,690.57 |
16,362.70 |
16,848.80 |
| 应付托管费 |
2,909.70 |
2,938.13 |
3,272.56 |
3,369.76 |
| 应付销售服务费 |
102,493.94 |
103,265.93 |
118,838.52 |
114,906.02 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
170,376.96 |
89,987.79 |
162,846.57 |
128,818.81 |
| 负债合计 |
10,435,835.08 |
3,020,688.43 |
2,440,797.01 |
3,201,191.58 |
| 所有者权益 |
| 实收基金 |
571,816,233.31 |
627,945,941.32 |
705,116,486.16 |
741,152,737.94 |
| 未分配利润 |
-1,612,343.32 |
-20,141,510.86 |
-60,794,479.39 |
-104,019,694.50 |
| 所有者权益合计 |
570,203,889.99 |
607,804,430.46 |
644,322,006.77 |
637,133,043.44 |
| 负债及所有者权益总计 |
580,639,725.07 |
610,825,118.89 |
646,762,803.78 |
640,334,235.02 |
微信公众号
证券之星APP
基本资料
